Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

  1. Barrios, C.H.
  2. Liu, M.-C.
  3. Lee, S.C.
  4. Vanlemmens, L.
  5. Ferrero, J.-M.
  6. Tabei, T.
  7. Pivot, X.
  8. Iwata, H.
  9. Aogi, K.
  10. Lugo-Quintana, R.
  11. Harbeck, N.
  12. Brickman, M.J.
  13. Zhang, K.
  14. Kern, K.A.
  15. Martin, M.
Aldizkaria:
Breast Cancer Research and Treatment

ISSN: 0167-6806,  1573-7217

Argitalpen urtea: 2010

Alea: 121

Zenbakia: 1

Orrialdeak: 121-131

Mota: Artikulua

DOI: 10.1007/S10549-010-0788-0 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus